These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


254 related items for PubMed ID: 27513991

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. HE3286 reduces axonal loss and preserves retinal ganglion cell function in experimental optic neuritis.
    Khan RS, Dine K, Luna E, Ahlem C, Shindler KS.
    Invest Ophthalmol Vis Sci; 2014 Aug 19; 55(9):5744-51. PubMed ID: 25139738
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Loss of Nrf2 exacerbates the visual deficits and optic neuritis elicited by experimental autoimmune encephalomyelitis.
    Larabee CM, Desai S, Agasing A, Georgescu C, Wren JD, Axtell RC, Plafker SM.
    Mol Vis; 2016 Aug 19; 22():1503-1513. PubMed ID: 28050123
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Calpain inhibition attenuates apoptosis of retinal ganglion cells in acute optic neuritis.
    Smith AW, Das A, Guyton MK, Ray SK, Rohrer B, Banik NL.
    Invest Ophthalmol Vis Sci; 2011 Jul 01; 52(7):4935-41. PubMed ID: 21613375
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Calpain inhibitor attenuated optic nerve damage in acute optic neuritis in rats.
    Das A, Guyton MK, Smith A, Wallace G, McDowell ML, Matzelle DD, Ray SK, Banik NL.
    J Neurochem; 2013 Jan 01; 124(1):133-46. PubMed ID: 23106593
    [Abstract] [Full Text] [Related]

  • 9. Spermidine alleviates severity of murine experimental autoimmune encephalomyelitis.
    Guo X, Harada C, Namekata K, Kimura A, Mitamura Y, Yoshida H, Matsumoto Y, Harada T.
    Invest Ophthalmol Vis Sci; 2011 Apr 01; 52(5):2696-703. PubMed ID: 21228387
    [Abstract] [Full Text] [Related]

  • 10. Selective Upregulation of SIRT1 Expression in Retinal Ganglion Cells by AAV-Mediated Gene Delivery Increases Neuronal Cell Survival and Alleviates Axon Demyelination Associated with Optic Neuritis.
    Ross AG, Chaqour B, McDougald DS, Dine KE, Duong TT, Shindler RE, Yue J, Liu T, Shindler KS.
    Biomolecules; 2022 Jun 14; 12(6):. PubMed ID: 35740955
    [Abstract] [Full Text] [Related]

  • 11. Early alpha-lipoic acid therapy protects from degeneration of the inner retinal layers and vision loss in an experimental autoimmune encephalomyelitis-optic neuritis model.
    Dietrich M, Helling N, Hilla A, Heskamp A, Issberner A, Hildebrandt T, Kohne Z, Küry P, Berndt C, Aktas O, Fischer D, Hartung HP, Albrecht P.
    J Neuroinflammation; 2018 Mar 07; 15(1):71. PubMed ID: 29514678
    [Abstract] [Full Text] [Related]

  • 12. Effects of a novel orally administered calpain inhibitor SNJ-1945 on immunomodulation and neurodegeneration in a murine model of multiple sclerosis.
    Trager N, Smith A, Wallace Iv G, Azuma M, Inoue J, Beeson C, Haque A, Banik NL.
    J Neurochem; 2014 Jul 07; 130(2):268-79. PubMed ID: 24447070
    [Abstract] [Full Text] [Related]

  • 13. Acriflavine, a HIF-1 inhibitor, preserves vision in an experimental autoimmune encephalomyelitis model of optic neuritis.
    Anders JJ, Elwood BW, Kardon RH, Gramlich OW.
    Front Immunol; 2023 Jul 07; 14():1271118. PubMed ID: 37942317
    [Abstract] [Full Text] [Related]

  • 14. Myelin-specific Th17 cells induce severe relapsing optic neuritis with irreversible loss of retinal ganglion cells in C57BL/6 mice.
    Larabee CM, Hu Y, Desai S, Georgescu C, Wren JD, Axtell RC, Plafker SM.
    Mol Vis; 2016 Jul 07; 22():332-41. PubMed ID: 27122964
    [Abstract] [Full Text] [Related]

  • 15. Retinal pathology in experimental optic neuritis is characterized by retrograde degeneration and gliosis.
    Manogaran P, Samardzija M, Schad AN, Wicki CA, Walker-Egger C, Rudin M, Grimm C, Schippling S.
    Acta Neuropathol Commun; 2019 Jul 17; 7(1):116. PubMed ID: 31315675
    [Abstract] [Full Text] [Related]

  • 16. Exploring experimental autoimmune optic neuritis using multimodal imaging.
    Manogaran P, Walker-Egger C, Samardzija M, Waschkies C, Grimm C, Rudin M, Schippling S.
    Neuroimage; 2018 Jul 15; 175():327-339. PubMed ID: 29627590
    [Abstract] [Full Text] [Related]

  • 17. Treatment with MDL 72527 Ameliorated Clinical Symptoms, Retinal Ganglion Cell Loss, Optic Nerve Inflammation, and Improved Visual Acuity in an Experimental Model of Multiple Sclerosis.
    Liu F, Alfarhan M, Baker L, Shenoy N, Liao Y, Henry-Ojo HO, Somanath PR, Narayanan SP.
    Cells; 2022 Dec 16; 11(24):. PubMed ID: 36552864
    [Abstract] [Full Text] [Related]

  • 18. Inflammatory demyelination induces axonal injury and retinal ganglion cell apoptosis in experimental optic neuritis.
    Shindler KS, Ventura E, Dutt M, Rostami A.
    Exp Eye Res; 2008 Sep 16; 87(3):208-13. PubMed ID: 18653182
    [Abstract] [Full Text] [Related]

  • 19. Laquinimod protects the optic nerve and retina in an experimental autoimmune encephalomyelitis model.
    Wilmes AT, Reinehr S, Kühn S, Pedreiturria X, Petrikowski L, Faissner S, Ayzenberg I, Stute G, Gold R, Dick HB, Kleiter I, Joachim SC.
    J Neuroinflammation; 2018 Jun 14; 15(1):183. PubMed ID: 29903027
    [Abstract] [Full Text] [Related]

  • 20. Timing of corticosteroid therapy is critical to prevent retinal ganglion cell loss in experimental optic neuritis.
    Dutt M, Tabuena P, Ventura E, Rostami A, Shindler KS.
    Invest Ophthalmol Vis Sci; 2010 Mar 14; 51(3):1439-45. PubMed ID: 19892867
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.